Tuesday, May 5, 2020
Wednesday, April 29, 2020
Right now, the whole world is going through a lot. Many children are having to stay at home with their parents. I decide to do my first YouTube reading of my book I Have A Secret for those children. Isolation and quarantine can bring out the worst in us and we have to be mindful of each other. I wanted to give something to the kids that can give them hope. This is a nighttime story to help them sleep soundly in a world of trauma. The book I Have A Secret by J.B. Terry-Smith can be found on Amazon.com!
or follow the link below
Monday, April 13, 2020
Justin B Terry-Smith - Drph (#JustinTerrySmith) talks about Corona Virus (COVID-19) vs. The Church
Thursday, March 5, 2020
****BREAKING*** Gov. Hogan declares a State of Emergency in Maryland to deal with Coronavirus & Corona Virus and HIV
#MarylandStateofEmergency | ****BREAKING*** Gov. Hogan declares a State of Emergency in Maryland to deal with what he calls:
"the rapidly evolving nature of this threat to public health, it is critical that we have the flexibility to access rersources," regarding Coronavirus. Three known Coronavirus cases have been discovered in Montgomery County, MD.
Potential school closures and other continuity plans are being reviewed by state agencies at this time. Hogans says Marylanders should not panic, but instead be prepared and informed. The Governor also says mass gatherings and other events may need to be postponed.
Updated info @ https://phpa.health.maryland.gov/Pages/Novel-coronavirus.aspx
This is a rapidly evolving situation and the Maryland Department of Health (MDH) will provide updates as they become available.
COVID-19 Testing and Confirmed Case Counts in Maryland
Number of patients tested for COVID-19: 31
Number of COVID-19 tests pending: 14
Number of negative COVID-19 tests: 17
Number of positive COVID-19 tests: 0
In December 2019, Chinese health officials announced they were investigating a pneumonia outbreak of unknown etiology (cause) in the city of Wuhan, China. At that time, it was reported that many of the cases were linked to a seafood and animal market in Wuhan. Since then, health officials have reported that the outbreak was caused by a novel coronavirus, and the illness has been named "coronavirus disease 2019" (abbreviated "COVID-19").
Since then, thousands of cases have been reported and some cases have been fatal. Cases of COVID-19 have been identified elsewhere in China, and in other countries, including in the United States.
There are many viruses in the coronavirus family that can cause illness in both humans and animals. Several coronaviruses commonly circulate among people all of the time, and cause mild to moderate illnesses, such as the common cold. Other coronaviruses commonly circulate only in animals. Rarely, animal coronaviruses can evolve and infect people and then spread between people as has been seen with MERS and SARS.
Symptoms of COVID-19
Commonly reported symptoms of COVID-19 infection include:
- Shortness of breath
While the exact incubation period for this coronavirus has not yet been determined, it is believed that most infected people will develop symptoms 2-14 days after they were exposed.
Many of the patients in the pneumonia outbreak caused by COVID-19 in Wuhan, China had some link to a large seafood and live animal market, suggesting animal-to-person spread. However, person-to-person spread is now widely occurring.
There is no vaccine available for COVID-19. In general, people can protect themselves and others against respiratory viruses by taking the following precautions:
- Wash your hands frequently with an alcohol-based hand sanitizer or soap & water.
- Cover your mouth and nose while coughing or sneezing.
- Avoid close contact with people who are sick.
- If you are sick, stay home from work or school.
- Avoid touching your eyes, nose, or mouth with unwashed hands.
- Practice good health habits.
It's not too late to get your flu shot! While the influenza vaccine does not protect against coronavirus infection, it can help keep you healthy during the flu season.
Currently, testing for COVID-19 can only be done at certain public health laboratories. Clinical laboratories do not have the ability to test for this particular virus, though they do have the ability to test for the other, more common coronaviruses that circulate in people all the time.
People with COVID-19 should receive supportive care. There is no specific antiviral treatment for this illness.
Guidance for people who recently traveled to China
Public health authorities have implemented travel procedures for travelers from China arriving in the United States.
- Guidance for travelers from other parts of China (outside Hubei Province) in the past 14 days includes:
- If you have fever, cough, or trouble breathing: CDC staff at the airport will evaluate you for illness. You will be taken to a medical facility for further evaluation and care. You may not be able to complete your travel itinerary.
- If you do not have symptoms: You will be allowed to reach your final destination. After arrival at your final destination, you will be asked to monitor your health for a period of 14 days from the time you left China. You will receive a health information card that tells you what symptoms to look for and what to do if you develop symptoms. During that time, you should stay home and limit interactions with others as much as possible. Your state or local health department will contact you for further follow up.
- Guidance for travelers from the Hubei Province, and other resources for returning travelers are available on the CDC Information for Travelers website.
Guidance for people who recently traveled to other countries with community spread of COVID-19
Monitor CDC Travel Health Notices webpage for important travel notifications.
Travelers returning from countries outside of China with community spread of COVID-19 are encouraged to monitor for symptoms, and call their healthcare provider if symptoms develop.
Saturday, January 25, 2020
Justin builds muscle healthily and goes from 130lbs to 165lbs in 2 years (Uses MRE) !!
Sunday, January 19, 2020
Sunday, December 22, 2019
NEW SURVEY UNCOVERS LACK OF KNOWLEDGE ABOUT HIV AMONG MILLENNIALS AND GEN Z
Murray Penner- Executive Director, North America, Prevention Access Campaign (PAC)
Peter Sklar M.D., director, clinical research, Merck Research Laboratories
While enormous strides have been made since the beginning of the HIV epidemic, the crisis is far from over. In fact, rates of HIV diagnoses among young adults in the U.S. have surged in recent years – accounting for more than half of new diagnoses – despite overall new diagnoses remaining stable.
In partnership with the Prevention Access Campaign (PAC), Merck launched Owning HIV: Young Adults and the Fight Ahead, a new campaign featuring results from a new survey to better understand young adults’ perceptions and beliefs about HIV.
The survey, fielded by Kantar Group between June 17 and August 5, 2019, was a cross-sectional, one-time online survey of approximately 1,600 US-based Gen Z (18-22) and millennials (23-36) who were self-reported HIV positive, or self-reported HIV negative/unknown, including Black/African American, Hispanic/Latinx, gay, bisexual, transgender and straight individuals. The goal of this study was to uncover attitudes and perceptions around HIV among young adults in the U.S. To date, this is the first survey to focus on the beliefs and perceptions about HIV among Generation Z (Gen Z) and millennials in the U.S.
Survey findings show a jarring trend of general confusion and insufficient knowledge of HIV and transmission, along with the existence of high-risk sexual practices, poor disease management, and stigmatizing behaviors among young adults.
Key Survey Findings Include:
•Survey findings showed a profound lack of accurate sex and HIV education among all participants, however the trend worsened in Gen Z
oMore than two-thirds of HIV-negative young adults said they were most concerned about getting HIV as compared to other sexually transmitted infections (STIs)
o54% of HIV-negative respondents did not report using condoms or pre-exposure prophylaxis (PrEP) to protect themselves against the HIV virus and other STIs
•Although millennials and Gen Z did not experience the start of the HIV epidemic firsthand, they still perpetuate the stigma seen in the early days of HIV
oMore than one quarter of HIV-negative millennials said they have avoided hugging, talking to or being friends with someone with HIV, and 30% said they would prefer not to interact socially with someone with HIV
oPeople with HIV who take HIV medicine as prescribed and get and keep an undetectable viral load (or stay virally suppressed) have effectively no risk of transmitting HIV to their HIV-negative sexual partners. The survey found that respondents had varying perceptions about what it means to be undetectable and the risk of transmitting the virus to another person.
o84% of Gen Z and 65% of millennials living with HIV who are abstaining from sex do so because of their HIV-positive status.
Murray Penner- Executive Director, North America, Prevention Access Campaign
Murray Penner is the Executive Director, North America of Prevention Access Campaign. He has a strong personal interest in helping people living with HIV achieve sexual health and well-being and reducing HIV stigma and shame. Prior to joining PAC, Murray served as Executive Director at NASTAD from 2015-2018 and served as NASTAD’s Deputy Executive Director and director of its care & treatment program from 2001-2015.
About Peter Sklar, M.D. director, clinical research, Merck Research Laboratories
Dr. Peter Sklar is a practicing physician who treats people living with HIV and maintains a clinical practice at the Partnership Comprehensive Care Program in Philadelphia, Pennsylvania. Dr. Sklar joined Merck in 2007 to advance the clinical research of new drug candidates for infectious diseases and has made significant contributions to the company’s virology portfolio. Dr. Sklar has also published numerous abstracts and articles in peer-reviewed journals and has served as the principal investigator on many clinical research protocols, including serving as site-PI of the U.S. Agency for Healthcare Research and Quality's HIV Research Network.